Patents by Inventor Andrew MORSCHAUSER

Andrew MORSCHAUSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241347
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Application
    Filed: October 7, 2021
    Publication date: August 4, 2022
    Applicant: Celularity Inc.
    Inventors: Eric Law, Andrew Morschauser, Aleksander Francki, Jennifer Paredes, Kathy Karasiewicz-Mendez, Allan Reduta, Vladimir Jankovic, Ivana Djuretic, Robert J. Hariri
  • Patent number: 11173182
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: November 16, 2021
    Assignee: Celularity Inc.
    Inventors: Eric Law, Andrew Morschauser, Aleksander Francki, Jennifer Paredes, Kathy Karasiewicz-Mendez, Allan Reduta, Vladimir Jankovic, Ivana Djuretic, Robert J. Hariri
  • Publication number: 20170252379
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Application
    Filed: October 8, 2015
    Publication date: September 7, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Eric LAW, Andrew MORSCHAUSER, Aleksandar FRANCKI, Jennifer PAREDES, Kathy E. KARASIEWICZ-MENDEZ, Allan REDUTA, Vladimir JANKOVIC, Ivana DJURETIC